FDA FEARS STRUCTURE/FUNCTION CLAIMS WILL BECOME "GIGANTIC LOOPHOLE"
This article was originally published in The Tan Sheet
Executive Summary
FDA FEARS STRUCTURE/FUNCTION CLAIMS WILL BECOME "GIGANTIC LOOPHOLE" that companies "will take advantage of" and make un-substantiated statements such as "widespread immune system claims," FDA Special Assistant for Policy Mitchell Zeller said at an Oct. 26 Food & Drug Law Institute meeting. Discussing the recently signed dietary supplement law, Zeller commented: "I wouldn't be honest if I didn't say that this [structure/function claims] provision gives the agency some pause."